top of page

WMCS FOR BURNS

 

The World Health Organisation, WHO, estimates that globally there are;

​

  • about 11 million burn victims injured severely enough to require medical attention every year

  • about 265,000 deaths every year as a result of Burn injuries

  • Non-fatal burns are a leading cause of morbidity, including prolonged hospitalisation, disfigurement and disability

 

WMCS Treatment Plan for Burns

 

WMCS is exceptionally effective as adjunctive therapy for severe burns patients. A typical WMCS treatment plan for burns includes:

​

  1. Gentle cleansing/debridement/shaving if needed.

  2. First WMCS treatment to be done before primary dressing is applied. (Typically 1.5 μA for 45 min)

  3. Apply primary dressing. (Typically a single permeable non-adherent tulle gras dressing like e.g. Jelonet™, Bactigras™ or Mepitel™)

  4. Repeat WMCS treatment daily over the primary dressing until the wound is healed. There is no need to change the primary dressing !

  5. Only remove the primary dressing when skin has healed.

​

Expected results from adjunct WMCS treatment for Burns:

​

  • The burned area will produce a thin layer of new skin after the first WMCS treatment, prior to the application of a primary dressing. Thus the area will be dry and significantly less painful in event of contact.

  • A single permeable dressing is applied after first treatment. There is no need for subsequent painful dressing changes. 

  • The patient will be pain free much faster. Typically the administration of pain medication can cease after only 1-2 days. High patient comfort.

  • Avoidance or minimization of the need for skin grafts. 

  • With daily WMCS treatments initiated from the day of injury, healing time is normally 5-10 days depending on the degree of the burn. 

  • Patients will be able to leave hospital faster, typically after only 1-2 weeks time.

 

Longer-term effects include significantly less scaring and improved pigmentation of the healed skin.

 

WMCS references for Burns

​

Pioneering work with WMCS treatment for burns with very positive results have been done and published by among others:

  • A. Limbourg and H.O. Rennekampff at Hannover Medical School in Germany

  • Defry Utama (Plastic and Reconstructive Surgery Faculty of Medicine University of Indonesia) & Aditya Wardhana (Burn Unit, Plastic Surgery Division, Cipto Mangunkusumo General National Hospital) in Jakarta Indonesia

  • Vicente Francisco Q. Firmalo at University of the East Ramon Magsaysay Memorial Medical Center in the Philippines.

​

Sample publications:

​

A reference video on the treatment of severe burns patients at Virachaivej International Hospital in Bangkok Thailand can be seen in this link:

Burns.png

Clinical Trials

​

Presently there is a blinded, placebo-controlled, randomized, prospective, single-centre study on paediatric deep dermal burns and scald injuries being performed at (and sponsored by) Paediatric Surgery, Kinder- und Jugendkrankenhaus auf der Bult in Hannover, Germany.  Principal Investigator: Mechthild Sinnig, MD.  Estimated study completion time:  Q2/Q3 2019.

​

​There is also a controlled, randomized, observer blinded, single centre and government (SingHealth) sponsored WMCS study performed on paediatric burns patients by KK Hospital in Singapore. Principal Investigator: Lim Jue Shuang Gale.

​

 

© 2019 by Wetling EU ApS. 

bottom of page